Investigational Drug Details
| Drug ID: | D202 |
| Drug Name: | LCQ908 |
| Synonyms: | Pradigastat |
| Type: | Chemical drug |
| DrugBank ID: | DB12866 |
| DrugBank Description: | Pradigastat has been used in trials studying the treatment of Non-alcoholic Fatty Liver Disease (NAFLD). |
| PubChem ID: | 53387035 |
| CasNo: | 956136-95-1 |
| Repositioning for NAFLD: | No |
| SMILES: | N(c1ccc(nc1)c1ccc(cc1)[C@@H]1CC[C@H](CC1)CC(=O)O)c1ccc(nc1)C(F)(F)F |
| Structure: |
|
| InChiKey: | GXALXAKNHIROPE-QAQDUYKDSA-N |
| Molecular Weight: | 455.48 |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | DGAT1 inhibitor |
| Therapeutic Category: | Hypolipidemic drug |
| Clinical Trial Progress: | Phase 2 completed (NCT01811472) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0069 | NCT01811472 | Phase 2 | Completed | Has Results | June 2013 | February 4, 2016 | Details |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|